Purespring Therapeutics
Purespring Therapeutics is a clinical-stage biotech developing precision therapies for kidney diseases, with 58 employees and $164M in funding. Its lead program targets Alport Syndrome, a rare inherited kidney disease.
The growth story
Purespring Therapeutics grew from 6 to 58 employees between 2020 and 2026, raising $164M along the way, most recently a Series B in October 2024.
About
Purespring develops genetically-driven therapies targeting podocytes, specialized kidney cells involved in most glomerular diseases. Its GlomThera platform delivers lower-dose genetic treatments directly to these cells, aiming for durable effects. The company focuses on both monogenic and non-monogenic kidney conditions affecting large underserved patient populations.
Founded in 2020, Purespring has raised $164M, including a Series B in October 2024. It employs 58 people, with a strong focus on research, which accounts for 21 roles. The company’s lead program, PS-003, is advancing toward clinical development for Alport Syndrome.
Founders and leadership
Purespring’s largest function is research, with 21 employees dedicated to this area. The company is led by a team with backgrounds in biotech and healthcare, supported by top investors like Syncona Partners and Forbion Capital Partners.
The Purespring Therapeutics org chart
Haseeb Ahmad (Chief Executive Officer) leads 28 mapped leaders with 10 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew
Headcount by function: Research 29 (+4% YoY), Business Development 10 (-9% YoY), Operations 4 (+33% YoY), Program and Project Management 3 (0% YoY), Healthcare Services 3 (+50% YoY), Quality Assurance 3 (0% YoY).
Talent flow
Purespring’s team draws heavily from institutions like Cell and Gene Therapy Catapult and King’s College London, with 7 hires each. Alumni have moved to companies like Teva Pharmaceuticals and UCL, indicating a strong network in biotech and academia.
Most common previous employers of Purespring Therapeutics staff: Cell and Gene Therapy Catapult (7), King's College London (7), GSK (5), NIGHTSTAR THERAPEUTICS (5), Imperial College London (5), Achilles Therapeutics (4). Former Purespring Therapeutics employees most often moved to Teva Pharmaceuticals (2), UCL (2), Gilde Healthcare (1), VectorBuilder (1), Xyra Group (1), Yellowstone Biosciences (1).
Alumni worth knowing
Web traffic
Traffic mix: 0% direct, 0% search, 0% social, 0% paid.
What this company is made of
Most common skills at Purespring Therapeutics: Research Skills (25), Communication (22), Biotechnology (19), Microsoft Excel (18), Microsoft Office (18), Leadership (18), Teamwork (17), Cell Culture (17).
Where the team actually sits
Purespring Therapeutics people are concentrated in England, United Kingdom (29), United Kingdom (12), London Area, United Kingdom (6), Basel, Switzerland (1).
Search footprint
Purespring Therapeutics attracts about 42 organic search visits a month, traffic worth roughly $0K a month if bought through ads. It gained 4 ranking keywords and lost 2 in the last period.
What employees say
- Compensation
- 3.00 / 5
- Career opportunities
- 1.00 / 5
- Senior management
- 3.00 / 5
- Work-life balance
- 5.00 / 5
Frequently asked
Purespring Therapeutics has 58 employees as of September 2026.
Purespring Therapeutics has raised $164M in total, most recently a Series B round in October 2024.
Haseeb Ahmad (Chief Executive Officer) sits at the top of Purespring Therapeutics's reporting structure, with 10 direct reports.
The most common previous employers of current Purespring Therapeutics staff are Cell and Gene Therapy Catapult (7 people), King's College London (7 people), GSK (5 people).
Former Purespring Therapeutics employees most often move to Teva Pharmaceuticals (2), UCL (2), Gilde Healthcare (1).
Purespring Therapeutics attracts about 42 organic search visits a month, worth roughly $0K a month in equivalent ad spend.
The most common skills among Purespring Therapeutics staff are Research Skills, Communication, Biotechnology, Microsoft Excel, Microsoft Office.
Purespring Therapeutics staff are concentrated in England, United Kingdom (29), United Kingdom (12), London Area, United Kingdom (6).
Purespring Therapeutics has about 29 people in Research, up 4% over the past year, as of September 2026.
Purespring Therapeutics has about 10 people in Business Development, down 9% over the past year, as of September 2026.
Computed from 50 current and 41 former Purespring Therapeutics profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.